<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02953210</url>
  </required_header>
  <id_info>
    <org_study_id>opioid free anesthesia</org_study_id>
    <nct_id>NCT02953210</nct_id>
  </id_info>
  <brief_title>Laparoscopic Cholecystectomy: General Anesthesia With Opioid Versus General Opioid Free Anesthesia</brief_title>
  <acronym>GALOFF</acronym>
  <official_title>Comparative Randomized Controlled Trial Study of General Balanced Anesthesia Based on Opioid and Opioid Sparing Balanced Anesthesia for Cholecystectomy Surgery Via Laparoscopy: Intraoperative and Postoperative Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Faculdade de Ciências Médicas da Santa Casa de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of opioid during surgery can cause side effects and may delay hospital discharge.
      Some studies have shown balanced sparing opioid anesthesia can optimize the side effects and
      and the time of discharge. In this compared controlled randomized study the aim is to
      evaluate the intraoperative and postoperative pain, hemodynamic effects, nausea/vomiting,
      postoperative ileus, sedation, urinary retention, time of discharge PACU Post anesthesia care
      unit and hospital.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients under laparoscopic cholecystectomy has moderate to severe pain. This study will
      compare intraoperative hemodynamic parameters under two techniques of general anesthesia: The
      primary outcome pain was used for planning the sample size of participants and considered a
      variation of 3 points on VAS (Visual analogic scale of pain). The secondaries outcomes
      nausea/vomiting, sedation, ileus paralytics, urinary retention, time of discharge (PACU) and
      hospital stay, and patient satisfaction will be recorded and analyzed.

      the patients will be allocated from randomized program in one of the two arms.

        1. Based opioid balanced anesthesia propofol, fentanyl, rocuronium and isoflurane

        2. Opioid sparing balance anesthesia with propofol, dexter- ketamine, clonidine,
           midazolan,isoflurane and lidocaine.

      At the end of procedure both groups will receive dexamethasone, ranitidine

      , ondansetron, keterolac IV and local infiltration of bupivacaine on trocar wounds as
      multimodal analgesia.

      General anesthesia opioid free seems to have less side effects than the general anesthesia
      based on opioid this study will compare it.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>60min after the surgery</time_frame>
    <description>will be asked pain at rest and movement and cough using the analog verbal scale of pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>nausea/ vomiting</measure>
    <time_frame>12, 24 and 36 hours after surgery</time_frame>
    <description>will be asked yes or not and how many times</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Paralytic ileus</measure>
    <time_frame>12, 24 and 36 hours after surgery</time_frame>
    <description>will be access with ultrasound movement of intestine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>first analgesic rescue requirement</measure>
    <time_frame>12 hours after the surgery</time_frame>
    <description>the first analgesic given at PACU when the patient asked for it</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pruritus</measure>
    <time_frame>12, 24 , 36 hours after surgery</time_frame>
    <description>yes or no, mild, moderate to serve</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sedation</measure>
    <time_frame>12, 24 and 26 hours after surgery</time_frame>
    <description>will be use the Ramasay scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time of discharge of PACU</measure>
    <time_frame>12 hour after the surgery</time_frame>
    <description>time when the patient will transfer to ward after the surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamics effects</measure>
    <time_frame>intraoperative</time_frame>
    <description>mean arterial pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>weight</measure>
    <time_frame>Baseline</time_frame>
    <description>measure in kilogram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>height</measure>
    <time_frame>Baseline</time_frame>
    <description>measure in cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gender</measure>
    <time_frame>Baseline</time_frame>
    <description>male or female</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>saturation of o2</measure>
    <time_frame>intraoperative</time_frame>
    <description>oximetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ETCO2</measure>
    <time_frame>intraoperative</time_frame>
    <description>capnography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>intraoperative</time_frame>
    <description>heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain</measure>
    <time_frame>12, 24 and 36 hours after the procedure</time_frame>
    <description>will be asked pain at rest and movement and cough using the analog verbal scale of pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Anesthesia Complication</condition>
  <condition>Nausea</condition>
  <condition>Vomiting</condition>
  <condition>Ileus Paralytic</condition>
  <condition>Hemodynamic Instability</condition>
  <arm_group>
    <arm_group_label>GF general free</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>pre induction midazolam 50ug.kg-1, clonidine 1ug.kg induction dexter ketamine 0.2mg.kg, lidocaine 1.5mg.kg, propofol 2mg.kg,rocuronium 0.6mg.kg maintenance isoflurane 1 CAM, lidocaine 2mg.kg.h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GBal general balanced</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>pre induction with midazolam 50 ug.kg induction fentanyl 3ug.kg, propofol 2mg.kg, rocuronium 0.6mg.k maintenance isoflurane 1 CAM and fentanyl as needed</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexter ketamine</intervention_name>
    <description>multimodal anesthesia without opioids ketamine as induction drug</description>
    <arm_group_label>GF general free</arm_group_label>
    <other_name>ketamine plus</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Hydrochloride</intervention_name>
    <description>continuous infusion intravenous</description>
    <arm_group_label>GF general free</arm_group_label>
    <other_name>xylocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl Hydrochloride</intervention_name>
    <description>intravenous</description>
    <arm_group_label>GBal general balanced</arm_group_label>
    <other_name>Fentanil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clonidine Hydrochloride</intervention_name>
    <description>clonidine intravenous pre induction</description>
    <arm_group_label>GF general free</arm_group_label>
    <other_name>Catapres</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam Hydrochloride</intervention_name>
    <description>premedication</description>
    <arm_group_label>GF general free</arm_group_label>
    <arm_group_label>GBal general balanced</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isoflurane Volatile Liquid</intervention_name>
    <description>maintenance of general anesthesia</description>
    <arm_group_label>GF general free</arm_group_label>
    <arm_group_label>GBal general balanced</arm_group_label>
    <other_name>isoflurane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium Injectable Solution</intervention_name>
    <description>induction of general anesthesia</description>
    <arm_group_label>GF general free</arm_group_label>
    <arm_group_label>GBal general balanced</arm_group_label>
    <other_name>rocuronium</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol 1 % Injectable Suspension</intervention_name>
    <description>induction of general anesthesia</description>
    <arm_group_label>GF general free</arm_group_label>
    <arm_group_label>GBal general balanced</arm_group_label>
    <other_name>propofol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone-21-Sulfobenzoate, Sodium Salt</intervention_name>
    <description>at the end of the procedure 4mg IV</description>
    <arm_group_label>GF general free</arm_group_label>
    <arm_group_label>GBal general balanced</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ranitidine Hydrochloride</intervention_name>
    <description>at the end of the procedure</description>
    <arm_group_label>GF general free</arm_group_label>
    <arm_group_label>GBal general balanced</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ondansetron Hydrochloride</intervention_name>
    <description>at the end of the procedure</description>
    <arm_group_label>GF general free</arm_group_label>
    <arm_group_label>GBal general balanced</arm_group_label>
    <other_name>ondasetron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketorolac Injectable Solution</intervention_name>
    <description>at the of the procedure</description>
    <arm_group_label>GF general free</arm_group_label>
    <arm_group_label>GBal general balanced</arm_group_label>
    <other_name>keterolac</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Hydrochloride</intervention_name>
    <description>at the end of the procedure for infiltration of trocar wounds</description>
    <arm_group_label>GF general free</arm_group_label>
    <arm_group_label>GBal general balanced</arm_group_label>
    <other_name>bupivacaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient under Laparoscopic cholecystectomy routine American Society of Anesthesiology
             ASA I or II

        Exclusion Criteria:

          -  chronic use of opioids

          -  Body mass index (BMI) &gt; 35 Kg.m-2

          -  Chronic heart failure, renal and hepatic failure

          -  illicit drugs users

          -  cognitive impairments
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>marcelo v perez, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculdade De Ciencias Medicas da Santa Casa de Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculdade de Ciências Médicas da Santa Casa de São Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>01221-020</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Faculdade de Ciências Médicas da Santa Casa de São Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>01333000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Bisgaard T. Analgesic treatment after laparoscopic cholecystectomy: a critical assessment of the evidence. Anesthesiology. 2006 Apr;104(4):835-46. Review.</citation>
    <PMID>16571981</PMID>
  </reference>
  <reference>
    <citation>De Oliveira GS Jr, Fitzgerald P, Streicher LF, Marcus RJ, McCarthy RJ. Systemic lidocaine to improve postoperative quality of recovery after ambulatory laparoscopic surgery. Anesth Analg. 2012 Aug;115(2):262-7. doi: 10.1213/ANE.0b013e318257a380. Epub 2012 May 14.</citation>
    <PMID>22584558</PMID>
  </reference>
  <results_reference>
    <citation>Collard V, Mistraletti G, Taqi A, Asenjo JF, Feldman LS, Fried GM, Carli F. Intraoperative esmolol infusion in the absence of opioids spares postoperative fentanyl in patients undergoing ambulatory laparoscopic cholecystectomy. Anesth Analg. 2007 Nov;105(5):1255-62, table of contents.</citation>
    <PMID>17959952</PMID>
  </results_reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2016</study_first_submitted>
  <study_first_submitted_qc>October 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2016</study_first_posted>
  <last_update_submitted>November 3, 2016</last_update_submitted>
  <last_update_submitted_qc>November 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Faculdade de Ciências Médicas da Santa Casa de São Paulo</investigator_affiliation>
    <investigator_full_name>Marcelo Vaz Perez</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>Clonidine</mesh_term>
    <mesh_term>Ranitidine bismuth citrate</mesh_term>
    <mesh_term>Ranitidine</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
    <mesh_term>Analgesics, Opioid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>June 13, 2017</submitted>
    <returned>October 27, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

